NCT03696355View on ClinicalTrials.gov

Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

April 2, 2021

Study Completion Date

September 4, 2022

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

GDC-0084

Given PO

RADIATION

radiation therapy

Both photon and proton therapy modalities will be allowed.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

Sponsors
All Listed Sponsors
collaborator

Kazia Therapeutics Limited

INDUSTRY

lead

St. Jude Children's Research Hospital

OTHER